LBA4 IPATential150: Phase III study of ipatasertib (ipat) plus abiraterone (abi) vs placebo (pbo) plus abi in metastatic castration-resistant prostate cancer (mCRPC)

Johann S. de Bono, Sergio Bracarda, Cora N. Sternberg, K.N. Chi, David Olmos, Shahneen Sandhu, Christophe Massard, Nobuaki Matsubara, B. Yа. Alekseev, Rustem Gafanov, Francis Parnis, Gary L. Buchschacher, Luis Corrales, Michael Borre, Gustavo Vasconcelos Alves, Josep Garcia, M-L. Harle-Yge, G. Chen, Matthew Wongchenko, Christopher J. Sweeney